Skip to main content

Want a detailed portfolio tracker?

Caris Life Sciences (CAI) P/E (2025 - 2026)

Caris Life Sciences (CAI) P/E from Jun 30, 2025 to Jul 21, 2026. The TTM Caris Life Sciences (CAI) P/E is 130.06. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Caris Life Sciences (CAI)

YearP/EChange
2026130.06-41.70%
2025223.08N/A

Comparison Caris Life Sciences (CAI) P/E with competitors

Caris Life Sciences (CAI) P/E is 130.06.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-99.94%
FGENFibroGen Inc0.24-99.82%
CHRSCoherus Biosciences Inc0.85-99.35%
FBIOFortress Biotech Inc0.95-99.27%
ORMPOramed Pharmaceuticals Inc1.50-98.84%
AGENAgenus Inc3.01-97.69%
INVAInnoviva Inc3.15-97.58%
VXRTVaxart Inc3.55-97.27%
CRMDCorMedix Inc3.63-97.21%
CVACCureVac N.V.4.45-96.58%
GLPGGalapagos NV4.86-96.26%
SRPTSarepta Therapeutics Inc4.88-96.25%
ABEOAbeona Therapeutics Inc5.39-95.86%
ABUSArbutus Biopharma Corp5.60-95.70%
ZVRAZevra Therapeutics Inc5.89-95.47%
SPROSpero Therapeutics Inc6.23-95.21%
CGENCompugen Ltd6.31-95.15%
RIGLRigel Pharmaceuticals6.87-94.72%
SLXNSilexion Therapeutics Corp7.30-94.39%
OMEROmeros Corporation9.26-92.88%
AUPHAurinia Pharmaceuticals Inc9.58-92.63%
PLXProtalix BioTherapeutics Inc10.89-91.63%
ACADAcadia Pharmaceuticals Inc11.73-90.98%
TBPHTheravance Biopharma Inc12.26-90.57%
ADMAAdma Biologics Inc12.42-90.45%
HRMYHarmony Biosciences Holdings Inc13.82-89.37%
SABSSAB Biotherapeutics Inc14.14-89.13%
NAGENiagen Bioscience Inc14.82-88.61%
INCYIncyte Corp15.82-87.83%
REGNRegeneron Pharmaceuticals Inc15.86-87.81%
PBYIPuma Biotechnology Inc17.32-86.69%
CPRXCatalyst Pharmaceuticals Inc17.44-86.59%
EXELExelixis Inc17.54-86.52%
TGTXTG Therapeutics Inc18.97-85.42%
MDXGMimedx Group Inc20.55-84.20%
XOMAXOMA Royalty Corp22.87-82.41%
ARGXArgen X SE24.30-81.32%
CTMXCytomX Therapeutics Inc24.82-80.92%
XOMAOXOMA Royalty Corp25.34-80.51%
HALOHalozyme Therapeutics Inc25.62-80.30%
XOMAPXOMA Royalty Corp25.67-80.26%
VRTXVertex Pharmaceuticals Inc27.99-78.48%
RPRXRoyalty Pharma plc - Class A28.69-77.94%
SLNOSoleno Therapeutics Inc29.02-77.69%
ASNDAscendis Pharma A/S30.09-76.87%
LGNDLigand Pharmaceuticals Inc - Class B37.91-70.85%
APLSApellis Pharmaceuticals Inc39.02-70.00%
BMRNBiomarin Pharmaceutical Inc42.21-67.54%
KRYSKrystal Biotech Inc45.34-65.14%
ONCBeiGene Ltd69.54-46.53%
PHARPharming Group N.V.75.03-42.32%
TECHBio-Techne Corp101.96-21.61%
VCELVericel Corp109.92-15.48%
ALNYAlnylam Pharmaceuticals Inc117.96-9.30%
GMABGenmab140.29+7.87%
TLXTelix Pharmaceuticals Ltd162.15+24.67%
CORTCorcept Therapeutics Inc212.86+63.66%